Friday, June 16, 2017 9:54:21 AM
Simply who they are working with.
Also I appreciate how many grants and military contracts Ekso has. The grants received don't show their value in Ekso's books, but the money spent definitely impacts ekso positively so I almost view these grants like money ekso spends on research.
Here's the main point though. When DARPA chose EKSO to give them multiple exoskeleton contracts for their TALOS project, it placed EKSO as the 'exoskeleton core' of a huge multilateral collaboration. Here is a shortened list of the collaborators for TALOS.
GOVERNMENT COLLABORATORS
* Lawrence Livermore National Laboratory
* Lincoln Laboratory
* Los Alamos National Laboratory
* MIT Lincoln Library
* NASA Johnson Space Center
* NASA Langley
* In-Q-Tel
INDUSTRY COLLABORATORS
* Boeing
* Honeywell
* Lockheed Martin
* Raytheon
* Rockwell Collins
* Thales
ACADEMIA COLLABORATORS
* Harvard University
* Johns Hopkins University
* Massachusetts Institute of Technology (MIT)
this isn't even the full list. See the rest:
https://translate.google.com/translate?hl=en&sl=ja&u=http://news.militaryblog.jp/e540203.html&prev=search
---
I'm a huge physics nerd and these guys are who I would be working for if I had a PhD.
I think the greatest minds in the world know a little something about value of collaboration. I think the TALOS project might be the greateset collaboration since the Fifth Solvay International Conference with the following physicists:
A. Piccard, E. Henriot, P. Ehrenfest, E. Herzen, Th. de Donder, E. Schrödinger, J.E. Verschaffelt, W. Pauli, W. Heisenberg, R.H. Fowler, L. Brillouin; P. Debye, M. Knudsen, W.L. Bragg, H.A. Kramers, P.A.M. Dirac, A.H. Compton, L. de Broglie, M. Born, N. Bohr; I. Langmuir, M. Planck, Marie Curie, H.A. Lorentz, A. Einstein, P. Langevin, Ch.-E. Guye, C.T.R. Wilson, O.W. Richardson
Planck, Dirac, Heisenberg, and Einstein used to be the smartest people on the planet. I think the 'complexity of intelligence' is something that is changing too. So in my eyes, these companies are somewhat analogous to the individuals doing scientific research before, but on a different magnitude. Maybe this is a stretch, but it's honestly how I see it.
Perhaps this quote form Admiral McRaven will help convince you (who at the time was in charge of the TALOS project). McRaven was also the person who lead the raid on Osama Bin Laden, communicating directly with the president as it went down.
“The unique collaboration effort is the future of how we should do business,” said McRaven.
https://www.stripes.com/news/special-ops-chief-mcraven-expects-iron-man-suit-by-2018-1.266995
A last point I'll mention that since In-Q-Tel is involved, it also likely means LAB-41 is actively involved with EKSO. LAB-41 is a special place where the collaborators can group think. I'm going to take a wild shot in the dark and say it's probably why Steph Curry was advocating for Ekso Bionics exoskeletons. He's of course an Under Armour representative, and Under Armour is actually one of the collaborators on TALOS (helping to test and refine fabric elements, etc.). So maybe these factors are unrelated, but if they are not, perhaps there will be more collaboration between these tech leading companies!
Recent EKSO News
- Ekso Bionics Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal • GlobeNewswire Inc. • 04/12/2024 12:00:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 09:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:08:54 PM
- Ekso Bionics Reports Record Annual Revenue of $18.3 Million • GlobeNewswire Inc. • 03/04/2024 09:05:00 PM
- Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 05:16:39 PM
- Ekso Bionics Announces $4.6 Million Registered Direct Offering • GlobeNewswire Inc. • 01/11/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 10:23:43 PM
- Ekso Bionics Launches GaitCoach Software for EksoNR • GlobeNewswire Inc. • 01/08/2024 09:05:00 PM
- Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 01/04/2024 10:05:12 PM
- Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29 • GlobeNewswire Inc. • 11/16/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:13:59 PM
- Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal • GlobeNewswire Inc. • 11/02/2023 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 08:17:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:10:19 PM
- Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38% • GlobeNewswire Inc. • 10/26/2023 08:05:00 PM
- Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023 • GlobeNewswire Inc. • 10/19/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 09:23:17 PM
- Ekso Bionics Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Include Personal Exoskeletons within a Medicare Benefit Category • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/11/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2023 01:44:10 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM